[1] Moss, G. P., Smith, P. A. S., & Tavernier, D. (1995). Glossary of class names of organic compounds and reactivity intermediates based on structure (IUPAC Recommendations 1995). Pure and applied chemistry, 67(8-9), 1307-1375.
[2] Parvarinezhad, S., & Salehi, M. (2021). Synthesis, characterization, anti-proliferative activity and chemistry computation of DFT theoretical methods of hydrazine-based Schiff bases derived from methyl acetoacetate and α-hydroxyacetophenone. Journal of Molecular Structure, 1225, 129086.
[3] Mahmoud, W. H., Deghadi, R. G., & Mohamed, G. G. (2016). Novel Schiff base ligand and its metal complexes with some transition elements. Synthesis, spectroscopic, thermal analysis, antimicrobial and in vitro anticancer activity. Applied Organometallic Chemistry, 30(4), 221-230.
[4] Lundgren, R. J., & Stradiotto, M. (2016). Key concepts in ligand design: an introduction. Ligand Design in Metal Chemistry: Reactivity and Catalysis, 1-14.
[5] Kumar, B., Devi, J., & Manuja, A. (2023). Synthesis, structure elucidation, antioxidant, antimicrobial, anti-inflammatory and molecular docking studies of transition metal (II) complexes derived from heterocyclic Schiff base ligands. Research on Chemical Intermediates, 49(6), 2455-2493.
[6] Devi, J., Kumar, S., Kumar, B., Asija, S., & Kumar, A. (2022). Synthesis, structural analysis, in vitro antioxidant, antimicrobial activity and molecular docking studies of transition metal complexes derived from Schiff base ligands of 4-(benzyloxy)-2-hydroxybenzaldehyde. Research on Chemical Intermediates, 48(4), 1541-1576.
[7] Pellei, M., Del Bello, F., Porchia, M., & Santini, C. (2021). Zinc coordination complexes as anticancer agents. Coordination Chemistry Reviews, 445, 214088.
[8] Neelakantan, M. A., Esakkiammal, M., Mariappan, S. S., Dharmaraja, J., & Jeyakumar, T. (2010). Synthesis, characterization and biocidal activities of some schiff base metal complexes. Indian Journal of Pharmaceutical Sciences, 72(2), 216.
[9] Devi, J., Sharma, S., Kumar, S., Kumar, B., Kumar, D., Jindal, D. K., & Das, S. (2022). Synthesis, characterization, in vitro antimicrobial and cytotoxic studies of Co (II), Ni (II), Cu (II), and Zn (II) complexes obtained from Schiff base ligands of 1, 2, 3, 4‐tetrahydro‐naphthalen‐1‐ylamine. Applied Organometallic Chemistry, 36(8), e6760.
[10] Kursunlu, A. N., Guler, E., Sevgi, F., & Ozkalp, B. (2013). Synthesis, spectroscopic characterization and antimicrobial studies of Co (II), Ni (II), Cu (II) and Zn (II) complexes with Schiff bases derived from 5-bromo-salicylaldehyde. Journal of Molecular Structure, 1048, 476-481.
[11] Behzad, M., Ghasemi, L., & Abbasi, A. (2025). Crystal structural characterization, molecular docking and ADMET analysis of new Cu (II) Schiff base complexes: Antiviral properties against SARS-CoV-2 and HPV. Polyhedron, 117549.
[12] Kumar, S., & Choudhary, M. (2023). New nickel (II) Schiff base complexes as potential tools against SARS-CoV-2 Omicron target proteins: an in silico approach. New Journal of Chemistry, 47(5), 2350-2371.
[13] Musib, D., Pal, M., Allam, U. S., & Roy, M. (2022). Brief History, Pathophysiology, Transmission of SARS-CoV-2 Virus, and Recent Advances on Transition Metal Complexes and Nanocomposites as the Potent Antiviral Agents from COVID-19 Perspectives. Nanostructured Biomaterials: Basic Structures and Applications, 1-48.
[14] Chhetri, A., Chettri, S., Rai, P., Mishra, D. K., Sinha, B., & Brahman, D. (2021). Synthesis, characterization and computational study on potential inhibitory action of novel azo imidazole derivatives against COVID-19 main protease (Mpro: 6LU7). Journal of molecular structure, 1225, 129230.
[15] Ghasemi, L., Esfahani, M. H., Abbasi, A., & Behzad, M. (2022). Synthesis and crystal structures of new mixed-ligand schiff base complexes containing N-donor heterocyclic co-ligands: Molecular docking and pharmacophore modeling studies on the main proteases of SARS-CoV-2 virus (COVID-19 disease). Polyhedron, 220, 115825.
[16] Qiao, Z., Wei, N., Jin, L., Zhang, H., Luo, J., Zhang, Y., & Wang, K. (2021). The Mpro structure-based modifications of ebselen derivatives for improved antiviral activity against SARS-CoV-2 virus. Bioorganic Chemistry, 117, 105455.
[17] Sahoo, R. N., Pattanaik, S., Pattnaik, G., Mallick, S., & Mohapatra, R. (2022). Review on the use of Molecular Docking as the First Line Tool in Drug Discovery and Development. Indian Journal of Pharmaceutical Sciences, 84(5).
[18] Potluri, H., Prasanth, D. S., & Atmakuri, L. R. (2021). In vivo antinociceptive effect of methanolic extract of Ipomoea marginata Desr. in rodents as well as in silico molecular docking of some phytoconstituents from the plant. Indian J. Pharm. Sci, 83(4), 732-741.
[19] Parvarinezhad, S., & Salehi, M. (2024). New Metal Complexes Incorporating Schiff Base Ligand Based on Hydrazide Moiety: Synthesis, Spectral Characterization, Electrochemical behavior, and Molecular Docking. Applied Chemistry Today, 19(73), 253-268.
[20] Parvarinezhad, S., Salehi, M., & Kubicki, M. (2025). New dinuclear Schiff base nickel complex: Investigation of intermolecular interactions via theoretical calculations, molecular docking studies and ADMET profiling approaches survey. Journal of Molecular Structure, 1326, 141016.
[21] Parvarinezhad, S., Salehi, M., & Kubicki, M. (2022). Synthesis, characterization, spectral studies and evaluation of noncovalent interactions in co-crystal of μ-oxobridged polymeric copper (II) complex derived from pyrazolone by theoretical studies. Journal of Molecular Structure, 1260, 132780.
[22] Parvarinezhad, S., Salehi, M., Eshaghi Malekshah, R., Kubicki, M., & Khaleghian, A. (2022). Synthesis, characterization, spectral studies two new transition metal complexes derived from pyrazolone by theoretical studies, and investigate anti‐proliferative activity. Applied Organometallic Chemistry, 36(3), e6563.
[23] Parvarinezhad, S., & Salehi, M. (2023). New pyrazolone-based Schiff base Cu (II) complexes: Synthesis, spectra, theoretical calculation and protein binding. Applied Chemistry Today, 69(18), 113-136.
[24] Deshpande, R. R., Tiwari, A. P., Nyayanit, N., and Modak, M. (2020) In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2. Eur. J. Pharmacol. 886, 173430.
